Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2026-02-26 00:00:00 ET · period of report 2026-02-24 · accession 0001193125-26-076999 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-02-26 | 2026-02-24 | CORT | WILSON JAMES N | Dir | J - Other | $0.00 | +89.4K | 1.13M | +9% | $0 |
| D | 2026-02-26 | 2026-02-24 | CORT | WILSON JAMES N | Dir | G - Gift | $0.00 | -89.4K | 0 | -100% | $0 |
| D | 2026-02-26 | 2026-02-24 | CORT | WILSON JAMES N | Dir | M - OptEx | $3.88 | +100.0K | 100.0K | New | +$388.0K |
| D | 2026-02-26 | 2026-02-24 | CORT | WILSON JAMES N | Dir | F - Tax | $36.48 | -10.6K | 89.4K | -11% | -$388.0K |
| D | 2026-02-26 | 2026-02-24 | CORT | WILSON JAMES N | Dir | M - OptEx | $0.00 | +100.0K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-24 | J | A | 89,364 | $0.00 | 1,134,532 | I | — | — | |
| 2 | Common | Common Stock | 2026-02-24 | G | D | 89,364 | $0.00 | 0 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-24 | M | A | 100,000 | $3.88 | 100,000 | D James N. Wilson and Pamela D. Wilson Trust | — | — | (F3) Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. |
| 4 | Common | Common Stock | 2026-02-24 | F | D | 10,636 | $36.48 | 89,364 | D | — | — | |
| 5 | Derivative | Stock option (right to buy) | 2026-02-24 | M | A | 100,000 | $0.00 | 0 | D | $3.88 · — to 2026-02-26 | 100,000 Common Stock | (F4) Fully exercisable. |